Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increase in curative treatment and survival of lung cancer in Norway 2001-2016.
Solberg S, Nilssen Y, Brustugun OT, Grimsrud TK, Haram PM, Helbekkmo N, Helland Å, Hjelde HH, Jakobsen B, Møller B, Petersen M, Strand TE, Wahl SGF, Aanerud M, Fjellbirkeland L. Solberg S, et al. Among authors: helbekkmo n. Eur J Epidemiol. 2019 Oct;34(10):951-955. doi: 10.1007/s10654-019-00536-z. Epub 2019 Jul 16. Eur J Epidemiol. 2019. PMID: 31313073
Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.
Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Fløtten O, Aasebø U. Strøm HH, et al. Among authors: helbekkmo n. Br J Cancer. 2013 Sep 17;109(6):1467-75. doi: 10.1038/bjc.2013.466. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963145 Free PMC article. Clinical Trial.
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Halvorsen TO, Stokke K, Killingberg KT, Raj SX, Sørhaug S, Brustugun OT, Fløtten Ø, Helbekkmo N, Hornslien K, Madebo T, Fluge S, Grønberg BH. Halvorsen TO, et al. Among authors: helbekkmo n. Acta Oncol. 2020 Sep;59(9):1051-1057. doi: 10.1080/0284186X.2020.1778179. Epub 2020 Jun 16. Acta Oncol. 2020. PMID: 32543258 Clinical Trial.
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.
Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å. Horndalsveen H, et al. Among authors: helbekkmo n. Mol Oncol. 2023 Mar;17(3):487-498. doi: 10.1002/1878-0261.13330. Epub 2022 Nov 22. Mol Oncol. 2023. PMID: 36330681 Free PMC article. Clinical Trial.
Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends.
Nilssen Y, Brustugun OT, Fjellbirkeland L, Grønberg BH, Haram PM, Helbekkmo N, Helland Å, Wahl SGF, Aanerud M, Solberg S. Nilssen Y, et al. Among authors: helbekkmo n. Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00046-9. doi: 10.1016/j.cllc.2024.04.002. Online ahead of print. Clin Lung Cancer. 2024. PMID: 38692990 Free article.
How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial.
Strøm HH, Bremnes RM, Sundstrøm SH, Helbekkmo N, Aasebø U. Strøm HH, et al. Among authors: helbekkmo n. Clin Lung Cancer. 2015 May;16(3):183-92. doi: 10.1016/j.cllc.2014.08.005. Epub 2014 Nov 13. Clin Lung Cancer. 2015. PMID: 25481662 Free article. Clinical Trial.
16 results